PL3019486T3 - Pochodne etynylu jako antagoniści metabotropowego receptora glutaminianu - Google Patents

Pochodne etynylu jako antagoniści metabotropowego receptora glutaminianu

Info

Publication number
PL3019486T3
PL3019486T3 PL14739714T PL14739714T PL3019486T3 PL 3019486 T3 PL3019486 T3 PL 3019486T3 PL 14739714 T PL14739714 T PL 14739714T PL 14739714 T PL14739714 T PL 14739714T PL 3019486 T3 PL3019486 T3 PL 3019486T3
Authority
PL
Poland
Prior art keywords
receptor antagonists
glutamate receptor
metabotropic glutamate
ethynyl derivatives
ethynyl
Prior art date
Application number
PL14739714T
Other languages
English (en)
Inventor
Georg Jaeschke
Lothar Lindemann
Rainer E. Martin
Antonio Ricci
Daniel Rueher
Heinz Stadler
Eric Vieira
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL3019486T3 publication Critical patent/PL3019486T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL14739714T 2013-07-08 2014-07-04 Pochodne etynylu jako antagoniści metabotropowego receptora glutaminianu PL3019486T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13175535 2013-07-08
EP14739714.5A EP3019486B1 (en) 2013-07-08 2014-07-04 Ethynyl derivatives as metabotropic glutamate receptor antagonists

Publications (1)

Publication Number Publication Date
PL3019486T3 true PL3019486T3 (pl) 2017-08-31

Family

ID=48745843

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14739714T PL3019486T3 (pl) 2013-07-08 2014-07-04 Pochodne etynylu jako antagoniści metabotropowego receptora glutaminianu

Country Status (27)

Country Link
US (2) US9682959B2 (pl)
EP (1) EP3019486B1 (pl)
JP (1) JP6116761B2 (pl)
KR (1) KR101767348B1 (pl)
CN (1) CN105358543B (pl)
AR (1) AR096824A1 (pl)
AU (1) AU2014289398B2 (pl)
BR (1) BR112015029724A2 (pl)
CA (1) CA2914282A1 (pl)
CL (1) CL2015003761A1 (pl)
CR (1) CR20150650A (pl)
DK (1) DK3019486T3 (pl)
EA (1) EA027882B1 (pl)
ES (1) ES2628206T3 (pl)
HU (1) HUE033270T2 (pl)
IL (1) IL242682B (pl)
MA (1) MA38659B1 (pl)
MY (1) MY181847A (pl)
PE (1) PE20160604A1 (pl)
PH (1) PH12015502692B1 (pl)
PL (1) PL3019486T3 (pl)
SG (1) SG11201510607RA (pl)
SI (1) SI3019486T1 (pl)
TW (1) TWI527808B (pl)
UA (1) UA116023C2 (pl)
WO (1) WO2015004007A1 (pl)
ZA (1) ZA201508410B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6603334B2 (ja) 2015-06-03 2019-11-06 エフ.ホフマン−ラ ロシュ アーゲー エチニル誘導体
US10034861B2 (en) 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
RS62551B1 (sr) 2017-12-14 2021-12-31 H Lundbeck As Kombinovane terapije koje obuhvataju primenu 1h-pirazolo[4,3-b]piridina
EP3728250A1 (en) 2017-12-20 2020-10-28 H. Lundbeck A/S PYRAZOLO[3,4-beta]PYRIDINES AND IMIDAZO[1,5-beta]PYRIDAZINES AS PDE1 INHIBITORS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5724364A (en) * 1980-06-02 1982-02-08 American Cyanamid Co 2-(2-imidazoline-2-yl)pyridines and quinolines, manufacture and intermediate and herbicidal use
FI90869C (fi) * 1986-11-14 1994-04-11 Tanabe Seiyaku Co Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
TWI292318B (en) 2003-03-10 2008-01-11 Hoffmann La Roche Imidazol-4-yl-ethynyl-pyridine derivatives
JP5635727B2 (ja) * 2004-10-07 2014-12-03 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. チアゾリルmglur5アンタゴニスト及びそれらの使用のための方法
US8389536B2 (en) * 2009-10-27 2013-03-05 Hoffmann-La Roche Inc. Positive allosteric modulators (PAM)
US8420661B2 (en) 2010-04-13 2013-04-16 Hoffmann-La Roche Inc. Arylethynyl derivatives
KR101576343B1 (ko) * 2011-04-26 2015-12-09 에프. 호프만-라 로슈 아게 피라졸리딘-3-온 유도체
CA2829170C (en) * 2011-04-26 2019-02-26 F. Hoffmann-La Roche Ag Ethynyl derivatives as positive allosteric modulators of the mglur5
UA110862C2 (uk) * 2011-10-07 2016-02-25 Ф. Хоффманн-Ля Рош Аг Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5

Also Published As

Publication number Publication date
MA38659A1 (fr) 2016-02-29
US20170217926A1 (en) 2017-08-03
HK1215573A1 (zh) 2016-09-02
CN105358543A (zh) 2016-02-24
CA2914282A1 (en) 2015-01-15
PE20160604A1 (es) 2016-07-03
AU2014289398A1 (en) 2015-11-26
MA38659B1 (fr) 2016-10-31
AU2014289398B2 (en) 2018-02-01
ES2628206T3 (es) 2017-08-02
EP3019486A1 (en) 2016-05-18
UA116023C2 (uk) 2018-01-25
US20160130255A1 (en) 2016-05-12
WO2015004007A1 (en) 2015-01-15
CR20150650A (es) 2016-01-11
SG11201510607RA (en) 2016-01-28
BR112015029724A2 (pt) 2017-07-25
EA201690162A1 (ru) 2016-05-31
AR096824A1 (es) 2016-02-03
PH12015502692A1 (en) 2016-03-14
MY181847A (en) 2021-01-08
EP3019486B1 (en) 2017-04-12
IL242682B (en) 2018-11-29
KR20160017026A (ko) 2016-02-15
US9751856B2 (en) 2017-09-05
CN105358543B (zh) 2018-06-12
US9682959B2 (en) 2017-06-20
TW201506019A (zh) 2015-02-16
PH12015502692B1 (en) 2018-08-24
CL2015003761A1 (es) 2016-07-15
JP6116761B2 (ja) 2017-04-19
TWI527808B (zh) 2016-04-01
JP2016523939A (ja) 2016-08-12
KR101767348B1 (ko) 2017-08-10
DK3019486T3 (en) 2017-06-19
ZA201508410B (en) 2017-08-30
EA027882B1 (ru) 2017-09-29
SI3019486T1 (sl) 2017-07-31
HUE033270T2 (en) 2017-11-28

Similar Documents

Publication Publication Date Title
IL255096A0 (en) Ethinylestradiol as metabotropic glutamate receptor modulators
IL233592A0 (en) p2x4 receptor antagonist
EP3020717A4 (en) P2x4 receptor antagonist
ZA201504974B (en) Indole carboxamide derivatives as p2x7 receptor antagonists
EP3038466A4 (en) 2,2-difluorodioxolo a2a receptor antagonists
IL233485A0 (en) History of spiroindoline as gonadotropin-releasing hormone receptor antagonists
IL244039B (en) Ethynyl derivatives
IL242682B (en) Ethynyl derivatives as metabotropic glutamate receptor antagonists
IL231439A (en) Ethylene history as modulators of metabotropic glutamate receptor
ZA201801736B (en) Progesterone receptor antagonist dosage form
PT2714647E (pt) Derivativos bifenil usados como antagonistas do recetor da glicagina
ZA201508209B (en) Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists
GB201304666D0 (en) Dopamine receptor antagonist
GB201213698D0 (en) Receptor antagonists II
GB201213699D0 (en) Receptor antagonists II